These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29661809)

  • 1. The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.
    Li R; Bar-Or A
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29661809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
    Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
    J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B cells in the immunopathogenesis of multiple sclerosis.
    Gharibi T; Babaloo Z; Hosseini A; Marofi F; Ebrahimi-Kalan A; Jahandideh S; Baradaran B
    Immunology; 2020 Aug; 160(4):325-335. PubMed ID: 32249925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing B cell contributions in multiple sclerosis.
    Li R; Patterson KR; Bar-Or A
    Nat Immunol; 2018 Jul; 19(7):696-707. PubMed ID: 29925992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
    Häusser-Kinzel S; Weber MS
    Front Immunol; 2019; 10():201. PubMed ID: 30800132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.
    O'Connor KC; Bar-Or A; Hafler DA
    J Clin Immunol; 2001 Mar; 21(2):81-92. PubMed ID: 11332657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.
    van Langelaar J; Rijvers L; Smolders J; van Luijn MM
    Front Immunol; 2020; 11():760. PubMed ID: 32457742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of B cells in multiple sclerosis: implications for B-cell-targeted therapy.
    Hirotani M; Niino M; Sasaki H
    Curr Med Chem; 2010; 17(28):3215-22. PubMed ID: 20666723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Sclerosis: New Aspects of Immunopathogenesis.
    Lazibat I; Rubinić Majdak M; Županić S
    Acta Clin Croat; 2018 Jun; 57(2):352-361. PubMed ID: 30431730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for multiple sclerosis targeting B cells.
    Milo R
    Croat Med J; 2019 Apr; 60(2):87-98. PubMed ID: 31044580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adaptative immunity and pathophysiology of multiple sclerosis].
    Salou M; Elong Ngono A; Garcia A; Michel L; Laplaud DA
    Rev Med Interne; 2013 Aug; 34(8):479-86. PubMed ID: 23622732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells and multiple sclerosis.
    Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic T cell cytokines in multiple sclerosis.
    Wagner CA; Roqué PJ; Goverman JM
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31611252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.
    Bhise V; Dhib-Jalbut S
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1069-89. PubMed ID: 27191526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of multiple sclerosis: an update on immunology.
    Hemmer B; Cepok S; Nessler S; Sommer N
    Curr Opin Neurol; 2002 Jun; 15(3):227-31. PubMed ID: 12045717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.